| Code | 12320 | ||||||||||
| MA number | 44/0033/13-S | ||||||||||
| Product Form: | imp 1x10,8 mg (striek.inj.napl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | AstraZeneca AB, Sweden | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | pre-filled syringe | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 15.04.1992 |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Zoladex LA depot 10,8 mg_10/2018.doc.doc
|
| PIL: |
PIL_Zoladex LA depot 10,8 mg_06.2024.pdf
|
| Safety feature | Yes |
| Data update: | 06.02.2018 |
